ROCHE HOLDING AG-BR (RHO.DE) Fundamental Analysis & Valuation

FRA:RHO • CH0012032113

404.8 EUR
-3.4 (-0.83%)
Last: Mar 3, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This RHO.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

RHO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 49 industry peers in the Pharmaceuticals industry. While RHO belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. RHO is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. RHO.DE Profitability Analysis

1.1 Basic Checks

  • RHO had positive earnings in the past year.
  • RHO had a positive operating cash flow in the past year.
  • Of the past 5 years RHO 4 years were profitable.
  • Of the past 5 years RHO 4 years had a positive operating cash flow.
RHO.DE Yearly Net Income VS EBIT VS OCF VS FCFRHO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

  • RHO has a better Return On Assets (9.95%) than 73.47% of its industry peers.
  • The Return On Equity of RHO (32.88%) is better than 83.67% of its industry peers.
  • RHO has a better Return On Invested Capital (24.24%) than 91.84% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for RHO is significantly above the industry average of 13.98%.
  • The last Return On Invested Capital (24.24%) for RHO is above the 3 year average (23.72%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.95%
ROE 32.88%
ROIC 24.24%
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
RHO.DE Yearly ROA, ROE, ROICRHO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

  • The Profit Margin of RHO (15.31%) is better than 61.22% of its industry peers.
  • RHO's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 33.79%, RHO belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
  • RHO's Operating Margin has been stable in the last couple of years.
  • Looking at the Gross Margin, with a value of 73.92%, RHO is in the better half of the industry, outperforming 69.39% of the companies in the same industry.
  • RHO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 33.79%
PM (TTM) 15.31%
GM 73.92%
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
RHO.DE Yearly Profit, Operating, Gross MarginsRHO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. RHO.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), RHO is creating value.
  • RHO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RHO.DE Yearly Shares OutstandingRHO.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
RHO.DE Yearly Total Debt VS Total AssetsRHO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • RHO has an Altman-Z score of 4.82. This indicates that RHO is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.82, RHO is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
  • RHO has a debt to FCF ratio of 2.50. This is a good value and a sign of high solvency as RHO would need 2.50 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.50, RHO is in the better half of the industry, outperforming 77.55% of the companies in the same industry.
  • A Debt/Equity ratio of 1.06 is on the high side and indicates that RHO has dependencies on debt financing.
  • RHO has a worse Debt to Equity ratio (1.06) than 63.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 2.5
Altman-Z 4.82
ROIC/WACC5.09
WACC4.76%
RHO.DE Yearly LT Debt VS Equity VS FCFRHO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

  • RHO has a Current Ratio of 1.29. This is a normal value and indicates that RHO is financially healthy and should not expect problems in meeting its short term obligations.
  • RHO's Current ratio of 1.29 is in line compared to the rest of the industry. RHO outperforms 44.90% of its industry peers.
  • RHO has a Quick Ratio of 1.02. This is a normal value and indicates that RHO is financially healthy and should not expect problems in meeting its short term obligations.
  • RHO has a Quick ratio of 1.02. This is comparable to the rest of the industry: RHO outperforms 55.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.02
RHO.DE Yearly Current Assets VS Current LiabilitesRHO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. RHO.DE Growth Analysis

3.1 Past

  • RHO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.41%.
  • The Earnings Per Share has been growing slightly by 0.49% on average over the past years.
EPS 1Y (TTM)4.41%
EPS 3Y-1.11%
EPS 5Y0.49%
EPS Q2Q%-0.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.24%

3.2 Future

  • Based on estimates for the next years, RHO will show a small growth in Earnings Per Share. The EPS will grow by 7.60% on average per year.
  • The Revenue is expected to grow by 3.87% on average over the next years.
EPS Next Y6.38%
EPS Next 2Y6.28%
EPS Next 3Y6%
EPS Next 5Y7.6%
Revenue Next Year1.92%
Revenue Next 2Y2.69%
Revenue Next 3Y3.36%
Revenue Next 5Y3.87%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RHO.DE Yearly Revenue VS EstimatesRHO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
RHO.DE Yearly EPS VS EstimatesRHO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

4

4. RHO.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.78, RHO is valued on the expensive side.
  • RHO's Price/Earnings ratio is in line with the industry average.
  • RHO is valuated rather cheaply when we compare the Price/Earnings ratio to 26.83, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 17.65 indicates a rather expensive valuation of RHO.
  • The rest of the industry has a similar Price/Forward Earnings ratio as RHO.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.95, RHO is valued a bit cheaper.
Industry RankSector Rank
PE 18.78
Fwd PE 17.65
RHO.DE Price Earnings VS Forward Price EarningsRHO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, RHO is valued a bit cheaper than the industry average as 61.22% of the companies are valued more expensively.
  • RHO's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. RHO is cheaper than 63.27% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.6
EV/EBITDA 13.12
RHO.DE Per share dataRHO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of RHO may justify a higher PE ratio.
PEG (NY)2.94
PEG (5Y)38.66
EPS Next 2Y6.28%
EPS Next 3Y6%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. RHO.DE Dividend Analysis

5.1 Amount

  • RHO has a Yearly Dividend Yield of 1.74%.
  • RHO's Dividend Yield is comparable with the industry average which is at 1.84.
  • Compared to an average S&P500 Dividend Yield of 1.82, RHO has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.74%

5.2 History

  • The dividend of RHO has a limited annual growth rate of 2.37%.
Dividend Growth(5Y)2.37%
Div Incr Years0
Div Non Decr Years0
RHO.DE Yearly Dividends per shareRHO.DE Yearly Dividends per shareYearly Dividends per share 2019 2026 2 4 6 8

5.3 Sustainability

  • 85.87% of the earnings are spent on dividend by RHO. This is not a sustainable payout ratio.
  • RHO's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP85.87%
EPS Next 2Y6.28%
EPS Next 3Y6%
RHO.DE Yearly Income VS Free CF VS DividendRHO.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
RHO.DE Dividend Payout.RHO.DE Dividend Payout, showing the Payout Ratio.RHO.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

RHO.DE Fundamentals: All Metrics, Ratios and Statistics

ROCHE HOLDING AG-BR

FRA:RHO (3/3/2026, 7:00:00 PM)

404.8

-3.4 (-0.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners40.79%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap327.58B
Revenue(TTM)N/A
Net Income(TTM)9.43B
Analysts71.72
Price Target400.71 (-1.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.74%
Yearly Dividend11.09
Dividend Growth(5Y)2.37%
DP85.87%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)14.77%
PT rev (3m)14.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 18.78
Fwd PE 17.65
P/S 4.84
P/FCF 22.6
P/OCF 15.47
P/B 10.4
P/tB 68.64
EV/EBITDA 13.12
EPS(TTM)21.55
EY5.32%
EPS(NY)22.93
Fwd EY5.66%
FCF(TTM)17.91
FCFY4.43%
OCF(TTM)26.16
OCFY6.46%
SpS83.57
BVpS38.91
TBVpS5.9
PEG (NY)2.94
PEG (5Y)38.66
Graham Number137.36
Profitability
Industry RankSector Rank
ROA 9.95%
ROE 32.88%
ROCE 30.98%
ROIC 24.24%
ROICexc 25.87%
ROICexgc 40.74%
OM 33.79%
PM (TTM) 15.31%
GM 73.92%
FCFM 21.43%
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
ROICexc(3y)28.94%
ROICexc(5y)29.11%
ROICexgc(3y)49.53%
ROICexgc(5y)49.86%
ROCE(3y)29.26%
ROCE(5y)30.68%
ROICexgc growth 3Y2.54%
ROICexgc growth 5Y-3.21%
ROICexc growth 3Y1.27%
ROICexc growth 5Y-3.5%
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 2.5
Debt/EBITDA 1.25
Cap/Depr 175.31%
Cap/Sales 9.87%
Interest Coverage 17.17
Cash Conversion 79.41%
Profit Quality 140.01%
Current Ratio 1.29
Quick Ratio 1.02
Altman-Z 4.82
F-Score8
WACC4.76%
ROIC/WACC5.09
Cap/Depr(3y)132.99%
Cap/Depr(5y)129.62%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.42%
Profit Quality(3y)129.49%
Profit Quality(5y)117.9%
High Growth Momentum
Growth
EPS 1Y (TTM)4.41%
EPS 3Y-1.11%
EPS 5Y0.49%
EPS Q2Q%-0.47%
EPS Next Y6.38%
EPS Next 2Y6.28%
EPS Next 3Y6%
EPS Next 5Y7.6%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.24%
Revenue Next Year1.92%
Revenue Next 2Y2.69%
Revenue Next 3Y3.36%
Revenue Next 5Y3.87%
EBIT growth 1Y10.03%
EBIT growth 3Y2.72%
EBIT growth 5Y-0.14%
EBIT Next Year23.19%
EBIT Next 3Y10.75%
EBIT Next 5Y8.97%
FCF growth 1Y12.91%
FCF growth 3Y-2.8%
FCF growth 5Y-2.91%
OCF growth 1Y19.07%
OCF growth 3Y-1.42%
OCF growth 5Y-2.14%

ROCHE HOLDING AG-BR / RHO.DE FAQ

Can you provide the ChartMill fundamental rating for ROCHE HOLDING AG-BR?

ChartMill assigns a fundamental rating of 5 / 10 to RHO.DE.


What is the valuation status of ROCHE HOLDING AG-BR (RHO.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to ROCHE HOLDING AG-BR (RHO.DE). This can be considered as Fairly Valued.


How profitable is ROCHE HOLDING AG-BR (RHO.DE) stock?

ROCHE HOLDING AG-BR (RHO.DE) has a profitability rating of 7 / 10.


What is the valuation of ROCHE HOLDING AG-BR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ROCHE HOLDING AG-BR (RHO.DE) is 18.78 and the Price/Book (PB) ratio is 10.4.


Can you provide the financial health for RHO stock?

The financial health rating of ROCHE HOLDING AG-BR (RHO.DE) is 5 / 10.